RxDoctor Payments DataLook up a doctor →

Murali Murty, MD

Radiation Oncology · Glendale, AZNPI 1013184423

Payments from drug & device makers

$17,051in general payments, 2019–2025

Across 699 payments — averaging $24.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Onmark, Inc.$3K
  • Novartis$1K
  • AstraZeneca$1K
  • Merck$825
  • AbbVie$810
  • Amgen$800
  • plus $9K from 54 others

What the payments were for

  • Travel & lodging$1,1387%
  • Food & beverage$15,80593%
  • Education$881%
  • Gifts$200%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Onmark, Inc.10$2,597
Novartis79$1,307
AstraZeneca(2 entities)55$1,143
Merck37$825
AbbVie39$810
Amgen40$800
Johnson & Johnson31$626
Sanofi33$612
Pfizer34$604
Novocure Inc.5$574
E.r. Squibb & Sons, L.L.C.29$511
Lilly USA, LLC18$420
Daiichi Sankyo Inc.15$378
Bayer20$349
Genmab U.S., Inc.18$332
Genentech USA, Inc.14$305
Puma Biotechnology, Inc.14$287
Jazz Pharmaceuticals Inc.8$283
Eisai Inc.12$252
Sumitomo Pharma America, Inc.3$250
Incyte Corporation9$201
Takeda Pharmaceuticals U.S.A., Inc.9$197
Pharmacyclics LLC, An Abbvie Company9$190
Seagen Inc.11$190
Ipsen Biopharmaceuticals, Inc11$184
GSK8$165
Visionrt, Inc.2$155
Boehringer Ingelheim7$147
Karyopharm Therapeutics Inc.8$147
Bristol Myers Squibb7$145
Deciphera Pharmaceuticals Inc.6$133
Blueprint Medicines Corporation6$131
Kyowa Kirin, Inc.6$121
Mirati Therapeutics, Inc.5$109
AMAG Pharmaceuticals, Inc.6$103
Regeneron Healthcare Solutions, Inc.4$101
EMD Serono, Inc.6$96
ADC Therapeutics America, Inc.4$89
AVEO Pharmaceuticals, Inc.4$82
Sun Pharmaceutical Industries Inc.5$72
Astellas Pharma US Inc3$69
Tersera Therapeutics LLC3$66
Clovis Oncology, Inc.4$66
Exelixis Inc.3$64
Lexicon Pharmaceuticals, Inc.3$57
Rigel Pharmaceuticals, Inc.2$55
Springworks Therapeutics, Inc.2$52
Acrotech Biopharma Inc.3$48
Gilead3$47
Stemline Therapeutics Inc.2$47
Servier Pharmaceuticals LLC2$43
Aurobindo Pharma USA, Inc.3$42
Tactile Systems Technology Inc2$40
Epizyme, Inc.2$38
Sobi, Inc2$36
Syndax Pharmaceuticals, Inc.1$32
Pharmaessentia USA Corporation1$32
Advanced Accelerator Applications2$30
Tolmar, Inc.1$22
Mylan Institutional Inc.1$21

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$17,051 in reported general payments places this provider in the 85th percentile of 138 radiation oncology providers in Arizona.

See all radiation oncology providers in Arizona →

Medicare billing

Part B allowed, 2024
$1,759,274
Medicare patients
367
Services billed
8,244

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other radiation oncology in Glendale

See the full list for Arizona →

Where these figures come from

Is this you, or does something look wrong? →